THE ADDITION OF TIAGABINE TO ANTIPSYCHOTIC MEDICATION IN THE TREATMENT OF RECENT-ONSET SCHIZOPHRENIA BY MODIFICATION OF DEVELOPMENTAL REORGANIZATION OF PREFRONTAL CIRCUITRY

被引：0
|
作者：
Shaskan, Noel Kate [1 ,2 ]
Thermenos, Heidi Wencel [2 ,3 ]
Seidman, Larry J. [2 ,3 ]
Green, Alan [3 ,4 ]
Woo, Tsung-Ung Wilson [1 ,3 ]
机构：
[1] McLean Hosp, Lab Cellular Neuropathol, Belmont, MA 02178 USA
[2] Beth Israel Deaconess Med Ctr, Dept Psychiat, Boston, MA 02215 USA
[3] Harvard Univ, Sch Med, Dept Psychiat, Boston, MA 02115 USA
[4] Dartmouth Coll, Hitchcock Med Ctr, Dartmouth Med Sch, Dept Psychiat, Hanover, NH 03756 USA
来源：
SCHIZOPHRENIA BULLETIN | 2011年 / 37卷
关键词：
D O I：
暂无
中图分类号：
R749 [精神病学];
学科分类号：
100205 ;
摘要：
引用
收藏
页码：320 / 320
页数：1
相关论文
共 45 条
  • [11] Rates of smoking in recent-onset schizophrenia patients receiving traditional versus atypical antipsychotic medications
    Yee-Bradbury, CM
    Nuechterlein, KH
    Morris, SE
    Gitlin, MJ
    Fogelson, DL
    Bartzokis, G
    Subotnik, KL
    SCHIZOPHRENIA RESEARCH, 2001, 49 (1-2) : 251 - 251
  • [12] Cerebellar motor learning deficits in medicated and medication-free men with recent-onset schizophrenia
    Coesmans, Michael
    Roder, Christian H.
    Smit, Albertine E.
    Koekkoek, Sebastiaan K. E.
    De Zeeuw, Chris I.
    Frens, Maarten A.
    van der Geest, Josef N.
    JOURNAL OF PSYCHIATRY & NEUROSCIENCE, 2014, 39 (01): : E3 - E11
  • [13] Modulation of Limbic Circuitry Predicts Treatment Response to Antipsychotic Medication: A Functional Imaging Study in Schizophrenia
    Adrienne C Lahti
    Martin A Weiler
    Henry H Holcomb
    Carol A Tamminga
    Karen L Cropsey
    Neuropsychopharmacology, 2009, 34 : 2675 - 2690
  • [14] Modulation of Limbic Circuitry Predicts Treatment Response to Antipsychotic Medication: A Functional Imaging Study in Schizophrenia
    Lahti, Adrienne C.
    Weiler, Martin A.
    Holcomb, Henry H.
    Tamminga, Carol A.
    Cropsey, Karen L.
    NEUROPSYCHOPHARMACOLOGY, 2009, 34 (13) : 2675 - 2690
  • [15] USING THE IPAP ALGORITHM TO PREDICT TIME TO TREATMENT RESPONSE IN RECENT-ONSET SCHIZOPHRENIA
    Kayo, Monica
    Tassell, Lyson
    Hiroce, Vivian Y.
    Menezes, Anny K. P. M.
    Oliveira, Graca M.
    Iso, Sandra
    Elkis, Helio
    SCHIZOPHRENIA RESEARCH, 2010, 117 (2-3) : 398 - 398
  • [16] Cardiovascular variability during treatment with haloperidol, olanzapine or risperidone in recent-onset schizophrenia
    Hempel, R. J.
    Tulen, J. H. M.
    van Beveren, N. J. M.
    Roder, C. H.
    Hengeveld, M. W.
    JOURNAL OF PSYCHOPHARMACOLOGY, 2009, 23 (06) : 697 - 707
  • [17] Pregnenolone: a possible new candidate for treatment of patients with prodromal and recent-onset schizophrenia
    Ritsner, M. S.
    Gibel, A.
    Shleifer, T.
    Boguslavsky, I.
    Zayed, A.
    Lermer, V.
    EARLY INTERVENTION IN PSYCHIATRY, 2008, 2 : A63 - A63
  • [18] Parental communication deviance: Its stability and the effect of family treatment in recent-onset schizophrenia
    Nugter, MA
    Dingemans, PMAJ
    Linszen, DH
    VanderDoes, AJW
    Gersons, BPR
    ACTA PSYCHIATRICA SCANDINAVICA, 1997, 95 (03) : 199 - 204
  • [19] Two years of continued early treatment for recent-onset schizophrenia: a randomised controlled study
    Grawe, R. W.
    Falloon, I. R. H.
    Widen, J. H.
    Skogvoll, E.
    ACTA PSYCHIATRICA SCANDINAVICA, 2006, 114 (05) : 328 - 336
  • [20] Treatment Adherence with Early Prescription of Long-Acting Injectable Antipsychotics in Recent-Onset Schizophrenia
    Viala, Annie
    Cornic, Francoise
    Vacheron, Marie-Noelle
    SCHIZOPHRENIA RESEARCH AND TREATMENT, 2012, 2012
12345